Clinical benefit of systemic treatment in patients with advanced pancreatic and gastrointestinal neuroendocrine tumours according to ESMO-MCBS and ASCO framework

LD de Hosson, LM van Veenendaal, Y Schuller, Wouter Zandee, W.W. de Herder, MET Tesselaar, HJ Klumpen, AME Walenkamp

Research output: Contribution to journalArticleAcademicpeer-review

13 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)3022-3027
Number of pages6
JournalAnnals of Oncology
Issue number12
Publication statusPublished - 2017

Research programs

  • EMC OR-01

Cite this